Frédéric Blanchard

7.5k total citations · 1 hit paper
146 papers, 6.1k citations indexed

About

Frédéric Blanchard is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Frédéric Blanchard has authored 146 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 53 papers in Molecular Biology and 35 papers in Immunology. Recurrent topics in Frédéric Blanchard's work include Cytokine Signaling Pathways and Interactions (47 papers), Bone Metabolism and Diseases (22 papers) and Bone health and treatments (15 papers). Frédéric Blanchard is often cited by papers focused on Cytokine Signaling Pathways and Interactions (47 papers), Bone Metabolism and Diseases (22 papers) and Bone health and treatments (15 papers). Frédéric Blanchard collaborates with scholars based in France, United States and Canada. Frédéric Blanchard's co-authors include Dominique Heymann, Françoise Rédiní, Benoît Le Goff, Céline Chipoy, Laurence Duplomb, Bénédicte Brounais, Marie‐Astrid Boutet, Valérie Trichet, Anne Godard and Céline Charrier and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Frédéric Blanchard

138 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

2007 621 citations Frédéric Blanchard et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frédéric Blanchard France	44	2.7k	2.4k	1.4k	833	701	146	6.1k
Shuli Li United States	46	2.1k 0.8×	1.2k 0.5×	1.2k 0.8×	746 0.9×	623 0.9×	239	6.9k
Shinya Kimura Japan	45	2.6k 1.0×	2.1k 0.9×	998 0.7×	1.1k 1.3×	682 1.0×	427	7.1k
Lukas Kenner Austria	52	5.1k 1.9×	3.0k 1.3×	2.2k 1.6×	920 1.1×	467 0.7×	225	10.4k
Franz Rödel Germany	48	2.6k 1.0×	2.7k 1.1×	1.3k 0.9×	1.1k 1.3×	194 0.3×	182	6.9k
Alain Mauviel France	64	6.3k 2.3×	2.1k 0.9×	1.2k 0.8×	925 1.1×	843 1.2×	145	11.2k
Koichi Sasaki Japan	21	3.8k 1.4×	1.7k 0.7×	616 0.4×	278 0.3×	845 1.2×	109	6.0k
Deborah V. Novack United States	43	4.5k 1.6×	2.6k 1.1×	1.2k 0.9×	211 0.3×	678 1.0×	81	6.9k
Shogo Nomura Japan	45	4.9k 1.8×	3.4k 1.4×	1.1k 0.8×	2.0k 2.4×	1.8k 2.5×	210	10.1k
Florian Otto Germany	24	3.1k 1.1×	1.4k 0.6×	672 0.5×	265 0.3×	613 0.9×	35	4.9k
Hiroyuki Kawashima Japan	34	2.4k 0.9×	1.4k 0.6×	307 0.2×	860 1.0×	640 0.9×	264	5.9k

Countries citing papers authored by Frédéric Blanchard

Since Specialization

Citations

This map shows the geographic impact of Frédéric Blanchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Blanchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Blanchard more than expected).

Fields of papers citing papers by Frédéric Blanchard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Blanchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Blanchard. The network helps show where Frédéric Blanchard may publish in the future.

Co-authorship network of co-authors of Frédéric Blanchard

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Blanchard. A scholar is included among the top collaborators of Frédéric Blanchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Blanchard. Frédéric Blanchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blanchard, Frédéric, Benoît Le Goff, Jérôme Guicheux, & Marie‐Astrid Boutet. (2025). Voyage au cœur de la synoviale : les nouvelles technologies spatiales pour la compréhension de sa physiopathologie. Revue du Rhumatisme. 92(6). 721–725.

Hannemann, Nicole, Monique Chambon, Dany Séverac, et al.. (2025). Monocyte‐Derived Macrophages‐Synovial Fibroblasts Crosstalk Unravels Oncostatin Signaling Network as a Driver of Synovitis in Osteoarthritis. Arthritis & Rheumatology. 78(1). 105–118. 2 indexed citations

Blanchard, Frédéric, et al.. (2023). New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis. Bone Research. 11(1). 26–26. 48 indexed citations

Blanchard, Frédéric, et al.. (2022). Temporal deep learning framework for retinopathy prediction in patients with type 1 diabetes. Artificial Intelligence in Medicine. 133. 102408–102408. 9 indexed citations

Briolay, Anne, et al.. (2020). Enhanced BMP-2/BMP-4 ratio in patients with peripheral spondyloarthritis and in cytokine- and stretch-stimulated mouse chondrocytes. Arthritis Research & Therapy. 22(1). 234–234. 11 indexed citations

Najm, Aurélie, Benjamin Ory, Thibaut Quillard, et al.. (2020). MicroRNA‐17‐5p Reduces Inflammation and Bone Erosions in Mice With Collagen‐Induced Arthritis and Directly Targets the JAK/STAT Pathway in Rheumatoid Arthritis Fibroblast‐like Synoviocytes. Arthritis & Rheumatology. 72(12). 2030–2039. 85 indexed citations

Najm, Aurélie, Frédéric Blanchard, & Benoît Le Goff. (2019). Micro-RNAs in inflammatory arthritis: From physiopathology to diagnosis, prognosis and therapeutic opportunities. Biochemical Pharmacology. 165. 134–144. 12 indexed citations

Blanchard, Frédéric, et al.. (2019). Explainable Structuring and Discovery of Relevant Cases for Exploration of High-Dimensional Data.. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations

Boutet, Marie‐Astrid, Aurélie Najm, Géraldine Bart, et al.. (2017). IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro. Annals of the Rheumatic Diseases. 76(7). 1304–1312. 105 indexed citations

10.

David, Emmanuelle, Franck Tirode, Marc Baud’huin, et al.. (2012). Oncostatin M Is a Growth Factor for Ewing Sarcoma. American Journal Of Pathology. 181(5). 1782–1795. 34 indexed citations

11.

Moriceau, Gatien, Benjamin Ory, Laura Mitrofan, et al.. (2010). Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process. Cancer Research. 70(24). 10329–10339. 74 indexed citations

12.

David, Emmanuelle, Pierre Guihard, Bénédicte Brounais, et al.. (2010). Direct anti‐cancer effect of oncostatin M on chondrosarcoma. International Journal of Cancer. 128(8). 1822–1835. 34 indexed citations

13.

Brounais, Bénédicte, Céline Chipoy, Kanji Mori, et al.. (2008). Oncostatin M Induces Bone Loss and Sensitizes Rat Osteosarcoma to the Antitumor Effect of Midostaurin In vivo. Clinical Cancer Research. 14(17). 5400–5409. 32 indexed citations

14.

Chipoy, Céline, Bénédicte Brounais, Valérie Trichet, et al.. (2007). Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53. Oncogene. 26(46). 6653–6664. 43 indexed citations

15.

Mori, Kanji, Martine Berreur, Frédéric Blanchard, et al.. (2007). Receptor activator of nuclear factor-κB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells. Oncology Reports. 18(6). 1365–71. 65 indexed citations

16.

Bitard, Juliette, Sophie Daburon, Laurence Duplomb, et al.. (2003). Mutations in the Immunoglobulin-like Domain of gp190, the Leukemia Inhibitory Factor (LIF) Receptor, Increase or Decrease Its Affinity for LIF. Journal of Biological Chemistry. 278(18). 16253–16261. 19 indexed citations

17.

Novella, Jean‐Luc, Isabella Morrone, Christoph Jochum, Nicolas Jovenin, & Frédéric Blanchard. (2001). Prévenir le syndrome d'épuisement de l'aidant du sujet âgé dépendant pour un meilleur maintien à domicile. 26(2). 135–150. 2 indexed citations

18.

Blanchard, Frédéric, Laurence Duplomb, Sylvie Raher, et al.. (1999). Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Mediates Internalization and Degradation of Leukemia Inhibitory Factor but Not Signal Transduction. Journal of Biological Chemistry. 274(35). 24685–24693. 62 indexed citations

19.

Heymann, Dominique, et al.. (1995). Upmodulation of αvβ1 integrin expression on human tumor cells by human interleukin for DA cells/leukemia inhibitory factor and oncostatin M: Correlation with increased cell adhesion on fibronectin. Journal of Cellular Biochemistry. 58(3). 305–314. 12 indexed citations

20.

Blanchard, Frédéric, et al.. (1988). Saturnisme du aux poteries vernissees. La Presse Médicale. 17(32). 1650–1650. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact